EUVIMEDEUVIMED entdecken
CrossrefInfokarte

GATA1 Knockdown Attenuates Osteoclast Differentiation and Subchondral Bone Loss in Experimental Osteoarthritis Through an SKP2-Associated Mechanism

Yongli Ding, Yapeng Zhu, Yong Jiang, Guangxi Li, Mingming Zhao, Yongzhou Luo

European Cells & Materials · 2026-10-30 · 59

DOI: 10.22203/ecm.v059a15 ↗
AbstractBibliografische Angaben

Abstract

Background: Osteoclast-mediated subchondral bone remodeling contributes to osteoarthritis (OA), but the role of GATA binding protein 1 (GATA1) remains unclear. This study examined whether GATA1 is associated with osteoclast differentiation and S-phase kinaseassociated protein 2 (SKP2) regulation in experimental OA. Methods: OA was induced by anterior cruciate ligament transection in rats. Bulk subchondral bone mRNA sequencing, intra-articular GATA1 knockdown, micro-computed tomography, histology, and tartrateresistant acid phosphatase (TRAP) staining were combined with nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) induced differentiation of RAW264.7 cells, gene-expression analyses, NFATc1 localization, Filamentous actin (F-actin)-ring assessment, an SKP2 promoter-reporter assay, and SKP2 rescue. Results: GATA1 expression was elevated in bulk OA subchondral bone. GATA1 knockdown was associated with higher bone mineral density and bone volume and fewer TRAP-positive osteoclasts in vivo. In RAW264.7 cells, GATA1 knockdown reduced TRAP-positive multinucleated cells, osteoclast-associated gene expression, NFATc1 nuclear localization, and F-actin-ring formation. GATA1 overexpression increased SKP2 promoter-reporter activity, whereas SKP2 overexpression partially reversed the effects of GATA1 knockdown. Conclusions: The findings support an SKP2-associated role for GATA1 in osteoclast differentiation and subchondral bone remodeling. Direct GATA1 binding to endogenous SKP2, cell-resolved localization in vivo, and validation in primary cells, human OA, and reciprocal epistasis models remain necessary.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →